FINANCIALS

EBS Emergent Biosolutions Inc 1367644

Income Statement
Revenue	ebs-20240930	293,800,000
Net Income	ebs-20240930	114,800,000
Profit Margin		39.07%

Balance Sheet
Current Assets	661,400,000
Assets	1,477,800,000
Current Liabilities	229,900,000
Liabilities	969,400,000
Equity	508,400,000
Shares Out	52,907,000

Cash Flow Statement
Operating Cash Flow	138,600,000
Investing Cash Flow	96,600,000

Market Analysis
Market Cap	380,398,600
Price	9.88
BVPS	9.61
PB	1.03
EPS	-11.24
PS	0.32
FCF	235,200,000

Dividends

Earnings

Find a discrepancy? The most accurate way to find company fundamental data is to view EBS documents filed with the SEC.

EBS Filings Clear

View A List of Tickers